Table 2.

Comparison of miR-106a detection in serum samples of GC patients and healthy volunteers using the nanobiosensor and qRT-PCR. Data are presented as the means of five replicates.

cancerous serum samples	miR-106a nanobiosensor		qRT-PCR		healthy serum samples	miR-106a nanobiosensor		qRT-PCR
	mean (pM)	RSD %	mean (pM)	RSD %		mean (pM)	RSD %	mean (pM)	RSD %
1	8.33	2.40	9.30	2.46	1	2.05	2.95	2.42	2.58
2	8.85	3.12	11.2	2.20	2	1.39	4.56	1.12	4.93
3	7.31	4.40	8.42	3.05	3	0.96	2.08	0.79	3.35
4	8.24	3.40	9.51	3.51	4	0.94	3.43	0.76	2.02
5	8.67	1.99	11.6	2.11	5	1.30	3.63	1.94	2.44
6	8.39	2.91	10.5	3.18	6	2.17	4.55	1.24	3.70
7	7.26	3.05	9.28	2.12	7	0.85	2.44	1.23	4.08
8	9.64	2.68	10.3	4.07	8	2.06	3.90	2.27	4.60
9	7.66	2.95	8.47	3.15	9	1.13	4.19	2.11	3.55
10	7.29	2.27	9.25	2.03	10	0.75	2.05	1.08	2.82
average	8.16		9.79		average	1.36		1.50